The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2021
Filed:
Feb. 22, 2019
Applicant:
National Institute of Biological Sciences, Beijing, Beijing, CN;
Inventors:
Niu Huang, Beijing, CN;
Shiming Peng, Beijing, CN;
Assignee:
National Institute of Biological Sciences, Beijing, Beijing, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/277 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/397 (2006.01); A61K 31/426 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61K 31/4402 (2006.01); A61K 31/4453 (2006.01); A61K 31/4965 (2006.01); A61K 31/505 (2006.01); A61K 31/535 (2006.01);
U.S. Cl.
CPC ...
A61K 31/277 (2013.01); A61K 9/0051 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); A61K 31/397 (2013.01); A61K 31/426 (2013.01); A61K 31/428 (2013.01); A61K 31/433 (2013.01); A61K 31/4402 (2013.01); A61K 31/4453 (2013.01); A61K 31/4965 (2013.01); A61K 31/505 (2013.01); A61K 31/535 (2013.01);
Abstract
The invention provides use of entacapone, an entacapone derivative or a stereoisomer, hydride, or pharmaceutically-acceptable salt thereof, in a person in need thereof, to treat or inhibit macular degeneration or age-related macular degeneration, and related compostions.